authors
- Deng, Yihong
- Polley, Eric C
- Herrin, Jeph
- Swarna, Kavya S
- Kent, David M
- Joseph S. Ross, MD, MHS
- Maron, Bradley A
- Mickelson, Mindy M
- McCoy, Rozalina G
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- July 17, 2025
published in
has subject area
- Adult
- Aged
- Blood Glucose
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Dipeptidyl-Peptidase IV Inhibitors
- Female
- Glucagon-Like Peptide-1 Receptor Agonists
- Heart Disease Risk Factors
- Humans
- Hypoglycemic Agents
- Male
- Middle Aged
- Risk Assessment
- Sodium-Glucose Transporter 2 Inhibitors
- Sulfonylurea Compounds
- Treatment Outcome
- United States